APA

Okita K., Morales A. M., Dean A. C., Johnson M. C., Lu V., Farahi J., Mandelkern M. A. & London E. D. (20190327). Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users. : Molecular psychiatry.

Chicago

Okita K, Morales A M, Dean A C, Johnson M C, Lu V, Farahi J, Mandelkern M A and London E D. 20190327. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users. : Molecular psychiatry.

Harvard

Okita K., Morales A. M., Dean A. C., Johnson M. C., Lu V., Farahi J., Mandelkern M. A. and London E. D. (20190327). Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users. : Molecular psychiatry.

MLA

Okita K, Morales A M, Dean A C, Johnson M C, Lu V, Farahi J, Mandelkern M A and London E D. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users. : Molecular psychiatry. 20190327.